Letter to the editor [1]

Atherosclerosis

Volumn 180, Issue 1, 2005, Pages 209-210

  Reunanen, Antti ^a   Roivainen, Merja ^a   Kleemola, Marjaana ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; VIRUS ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY TITER; CHLAMYDOPHILA PNEUMONIAE; CORONARY RISK; ENTEROVIRUS INFECTION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; MALE; MYCOPLASMA PNEUMONIA; PRIORITY JOURNAL; VIRUS PATHOGENESIS; CORONARY ARTERY ATHEROSCLEROSIS; EPIDEMIOLOGY; IMMUNOLOGY; MICROBIOLOGY; MYCOPLASMA PNEUMONIAE; NOTE;

ANTIBODIES, BACTERIAL; CORONARY ARTERIOSCLEROSIS; HUMANS; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; SEROEPIDEMIOLOGIC STUDIES;

EID: 22844442440     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.12.032     Document Type: Letter

References (3)

1. Y. Momiyama, R. Ohmori, H. Taniguchi, H. Nakamura, and F. Ohsuzu Association of Mycoplasma pneumoniae infection with coronary artery disease and its interaction with chlamydial infection Atherosclerosis 176 2004 139 144
2. A. Reunanen, M. Roivainen, and M. Kleemola Enterovirus, mycoplasma and other infections as predictors for myocardial infarction J Intern Med 252 2002 421 429
3. J. Zhu, J. Nieto, B.D. Horne, J.L. Anderson, J.B. Muhlestein, and S.E. Epstein Prospective study of pathogen burden and risk of myocardial infarction and death Circulation 103 2001 45 51